Question 1

What are the most cited papers from Targepeutics (United States)?

Accepted Answer

The most cited paper from Targepeutics (United States) is "IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma" (Julian S. Rechberger, Kendra A. Porath, Liang Zhang et al., 2022), with 13 citations. Next come "Targeting IL-13Rα2 for effective treatment of malignant peripheral nerve sheath tumors in mouse models" (7) and "Radiotherapy plus neoadjuvant and concomitant IL-13Rα2-directed immunotoxin therapy for diffuse intrinsic pontine glioma" (2).

Question 2

Which research topics does Targepeutics (United States) publish most on?

Accepted Answer

By volume in 2022-now: Toxin Mechanisms and Immunotoxins, Chronic Lymphocytic Leukemia Research, Lung Cancer Treatments and Mutations and HER2/EGFR in Cancer Research.

Question 3

Which fields of science does Targepeutics (United States) work in?

Accepted Answer

In all years, 56% of research at Targepeutics (United States) is in Health Sciences, 41% in Life Sciences. Its largest fields are Medicine (56%), Immunology and Microbiology (26%), Biochemistry, Genetics and Molecular Biology (15%). It does 1.3× the world's share of Health Sciences.

Question 4

Is Targepeutics (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 270% higher than in 2018-2021.